SavedAdd your journal

Journals / Journal of Health Sciences and Medicine / 2021 / Cilt: 4 - Sayı: 4

The impact and relationship of inflammatory markers and radiologic involvement in the COVID-19 patients

Merve Sefa SAYAR
Dilek BULUT
Sebahattin ÇELİK
Veysel BURULDAY
Remzi SARIKAYA
Nurettin KURT
Pages
416–421
Publication Date
2021-07-15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Except for thrombocytopenia, all variables such as ferritin, D-dimer, thoracic computerized tomography (CT) involvement rates were significantly poorer in the patients requiring the care in ICU than the patients in wards (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: In the study, it was aimed to investigate the relationship between inflammatory markers and radiology in COVID-19 patients.
📊
Key Findings & Data:Material and Method: The study was conducted in the quarantine wards of a tertiary hospital between March and June 2020.
💡
Conclusion & Impact:Except for thrombocytopenia, all variables such as ferritin, D-dimer, thoracic computerized tomography (CT) involvement rates were significantly poorer in the patients requiring the care in ICU than the patients in wards (p
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:COVID-19 · intensive care unit · prognosis

Abstract

Aim: In the study, it was aimed to investigate the relationship between inflammatory markers and radiology in COVID-19 patients. Material and Method: The study was conducted in the quarantine wards of a tertiary hospital between March and June 2020. Patients with a definite diagnosis of COVID-19 were included in the study. The lung damage of the patients caused by COVID-19 was determined by computed tomography and the relationship between lung damage and inflammatory markers was examined. Results: The mean age of 259 COVID-19 patients included in the study was 61.96 ± 14.076. Except for thrombocytopenia, all variables such as ferritin, D-dimer, thoracic computerized tomography (CT) involvement rates were significantly poorer in the patients requiring the care in ICU than the patients in wards (p

🔖

Cite This Article

SAYAR, M. S., BULUT, D., ÇELİK, S., BURULDAY, V., SARIKAYA, R., KURT, N. (2021). The impact and relationship of inflammatory markers and radiologic involvement in the COVID-19 patients. Journal of Health Sciences and Medicine, Cilt: 4 - Sayı: 4, 416–421. https://ajindex.com/articles/776867

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Khabbaz R, Beth BP, Schuchat A, et al. Emerging and reemerging infectious disease threats. In: Mandel, Dougles, and Bennett’s Principles and Practice of Infectious Disease, Bennett JE, Dolin R, Blaser MJ (eds). 8rd ed. Philadelphia: Elsevier; 2015: 158-77. World Health Organization: COVID-19 Weekly Epidemiological Update-24 November 2020. Available at: Accessed November 25, 2020.
  2. Cao W, Li T. COVID-19: towards understanding of pathogenesis. Cell Res 2020; 5: 367–9.
  3. Shi Y, Yu X, Zhao H, et al. Host susceptibility to severe COVID-19 and establishment of a host risk score: Findings of 487 cases outside Wuhan. Crit Care 2020; 1: 2–5.
  4. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. Jama 2020; 13: 1239-42.
  5. Zhai P, Ding Y, Wu X, et al. The epidemiology, diagnosis and treatment of COVID-19. Int J Antimicrob Agents 2020; 5: 105955. TR Ministry of Health, General Directorate of Public Health. COVID-19 (SARS-CoV-2 Infection) Treatment of Adult Patients 19 June 2020. Available at:. Accessed July 1, 2020.
  6. Pan F, Ye T, Sun P. Time course of lung changes at chest ct during recovery from coronavirus disease 2019 (COVID-19). Radiology 2020; 295: 715–21.
  7. Li K, Wu J, Wu F, et al. The clinical and chest ct features associated with severe and critical COVID-19 pneumonia. Invest Radiol 2020; 6: 327-31. China-WHO Expert team. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Available at. Accessed by July 1,2020. World Health Organization: Clinical Care Severe Acute Respiratory Infection: Tool kit. Available at:. Accessed by July 1, 2020.
  8. Harapan H, Itoh N, Yufika A, et al. Coronavirus disease 2019 (COVID-19): A literature review. J Infect Public Health 2020; 5: 667–73.
  9. Sohrabi C, Alsafi Z, O’Neill N, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg 2020; 76: 71–6.
  10. Shi Y, Wang G, Cai XP, et al. An overview of COVID-19. J Zhejiang Univ Sci B 2020; 5: 343–60.
  11. Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis 2020; 94: 91–5.
  12. Tufan A, Avanoğlu Güler A, Matucci-Cerinic M. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs. Turk J Med Sci 2020; 50: 620–32.
  13. Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wu